Cover Image
Market Research Report

Global Flow Diversion Aneurysm Treatment Market 2018-2022

Published by TechNavio (Infiniti Research Ltd.) Product code 366013
Published Content info 115 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Flow Diversion Aneurysm Treatment Market 2018-2022
Published: July 2, 2018 Content info: 115 Pages
Description

About flow diversion aneurysm treatment

Flow diversion aneurysm treatment consists of the use of endovascular devices such as flow-diverting stents (FDS) and intrasaccular flow disruption devices. These devices are used in the treatment of intracranial aneurysms (IAs).

Technavio's analysts forecast the Global Flow Diversion Aneurysm Treatment Market to grow at a CAGR of 14% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the flow diversion aneurysm treatment market. To calculate the market size, the report considers the revenue generated from the sales of products such as flow-diverting stents (FDS) and intrasaccular flow disruption devices.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Flow Diversion Aneurysm Treatment Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Acandis
  • Medtronic
  • Phenox
  • Stryker

Market driver

  • Increasing prevalence of IAs and associated risk factors
  • For a full, detailed list, view our report

Market challenge

  • Lack of awareness and access to flow diversion procedures in emerging countries
  • For a full, detailed list, view our report

Market trend

  • Increasing R&D focus
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents
Product Code: IRTNTR22009

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Segmentation by product
  • Comparison by product
  • FDS
  • Intrasaccular flow disruption devices
  • Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Flow diversion aneurysm treatment market in EMEA
  • Flow diversion aneurysm treatment market in Americas
  • Flow diversion aneurysm treatment market in APAC
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Increasing R&D focus
  • Expanding indications

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Acandis
  • Medtronic
  • Phenox
  • Stryker
  • TERUMO CORPORATION

PART 15: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Global neurovascular devices market
  • Exhibit 02: Global neurovascular devices market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Global flow diversion aneurysm treatment market
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global flow diversion aneurysm treatment market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 09: Global flow diversion aneurysm treatment market - Year-over-year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2017
  • Exhibit 18: Global flow diversion aneurysm treatment market - Market share by product 2017-2022 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Global FDS market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 21: Global FDS market - Year-over-year growth 2018-2022 (%)
  • Exhibit 22: Global intrasaccular flow disruption devices market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 23: Global intrasaccular flow disruption devices market - Year-over-year growth 2018-2022 (%)
  • Exhibit 24: Market opportunity by product
  • Exhibit 25: Customer landscape
  • Exhibit 26: Global flow diversion aneurysm treatment market - Market share by geography 2017-2022 (%)
  • Exhibit 27: Regional comparison
  • Exhibit 28: Flow diversion aneurysm treatment market in EMEA - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 29: Flow diversion aneurysm treatment market in EMEA - Year-over-year growth 2018-2022 (%)
  • Exhibit 30: Top two countries in EMEA
  • Exhibit 31: Flow diversion aneurysm treatment market in Americas - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 32: Flow diversion aneurysm treatment market in Americas - Year-over-year growth 2018-2022 (%)
  • Exhibit 33: Top two countries in Americas
  • Exhibit 34: Flow diversion aneurysm treatment market in APAC - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 35: Flow diversion aneurysm treatment market in APAC - Year-over-year growth 2018-2022 (%)
  • Exhibit 36: Top two countries in APAC
  • Exhibit 37: Market opportunity
  • Exhibit 38: Vendor landscape
  • Exhibit 39: Landscape disruption
  • Exhibit 40: Vendors covered
  • Exhibit 41: Vendor classification
  • Exhibit 42: Market positioning of vendors
  • Exhibit 43: Acandis - Overview
  • Exhibit 44: Acandis - Product segments
  • Exhibit 45: Acandis - Organizational developments
  • Exhibit 46: Acandis - Geographic focus
  • Exhibit 47: Acandis - Segment focus
  • Exhibit 48: Acandis - Key offerings
  • Exhibit 49: Acandis - Key customers
  • Exhibit 50: Medtronic - Overview
  • Exhibit 51: Medtronic - Business segments
  • Exhibit 52: Medtronic - Organizational developments
  • Exhibit 53: Medtronic - Geographic focus
  • Exhibit 54: Medtronic - Segment focus
  • Exhibit 55: Medtronic - Key offerings
  • Exhibit 56: Medtronic - Key customers
  • Exhibit 57: Phenox - Overview
  • Exhibit 58: Phenox - Product segments
  • Exhibit 59: Phenox - Organizational developments
  • Exhibit 60: Phenox - Geographic focus
  • Exhibit 61: Phenox - Segment focus
  • Exhibit 62: Phenox - Key offerings
  • Exhibit 63: Phenox - Key customers
  • Exhibit 64: Stryker - Overview
  • Exhibit 65: Stryker - Business segments
  • Exhibit 66: Stryker - Organizational developments
  • Exhibit 67: Stryker - Geographic focus
  • Exhibit 68: Stryker - Segment focus
  • Exhibit 69: Stryker - Key offerings
  • Exhibit 70: Stryker - Key customers
  • Exhibit 71: TERUMO CORPORATION - Overview
  • Exhibit 72: TERUMO CORPORATION - Business segments
  • Exhibit 73: TERUMO CORPORATION - Organizational developments
  • Exhibit 74: TERUMO CORPORATION - Geographic focus
  • Exhibit 75: TERUMO CORPORATION - Segment focus
  • Exhibit 76: TERUMO CORPORATION - Key offerings
  • Exhibit 77: TERUMO CORPORATION - Key customers
Back to Top